Robert Polke
Plus aucun poste en cours
Historique de carrière de Robert Polke
Anciens postes connus de Robert Polke
Sociétés | Poste | Début | Fin |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - | - |
ENDO INTERNATIONAL PLC | Directeur des opérations | 01/11/2020 | - |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | - | - |
Circa Pharmaceuticals, Inc. | Directeur des opérations | - | - |
BML Pharmaceuticals, Inc.
BML Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services BML Pharmaceuticals, Inc. provides research and develops proprietary prescriptive pharmaceutical products in the area of cancer treatment. The company is based in Chadds Ford, PA. | Directeur des opérations | - | - |
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Directeur des opérations | - | - |
PAR PHARMACEUTICAL COMPANIES, INC. | Directeur Technique/Scientifique/R&D | 16/06/2010 | 28/04/2014 |
Corporate Officer/Principal | - | - |
Formation de Robert Polke
St. John's University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 8 |
Irlande | 2 |
Opérationnelle
Chief Operating Officer | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PFIZER, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
BML Pharmaceuticals, Inc.
BML Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services BML Pharmaceuticals, Inc. provides research and develops proprietary prescriptive pharmaceutical products in the area of cancer treatment. The company is based in Chadds Ford, PA. | Commercial Services |
Circa Pharmaceuticals, Inc. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Robert Polke
- Expérience